Skip to main content

Parasomnia

  • Chapter
  • First Online:
Sleep Medicine and Mental Health

Abstract

Parasomnias are a group of sleep disorders characterized by abnormal, unpleasant motor, verbal, and/or behavioral events that occur during sleep or wake to sleep transitions. They are classified as nonrapid eye movement (NREM) and rapid eye movement (REM) sleep parasomnias depending on the stage of sleep they normally occur. Sleep disturbance, emotional stress, and safety are common concerns. Several psychiatric disorders and medication commonly used to treat psychiatric symptoms can exacerbate parasomnias. On the contrary, parasomnias can cause emotional stress and significant sleep disruption to worsen psychiatric symptoms. This review aims to highlight the pathophysiology and clinical features of various types of parasomnias, appropriate diagnostic and pharmacological approaches, and parasomnias link to mental health disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mahowald MW, Bornemann MC, Schenck CH. Parasomnias. Semin Neurol. 2004;3:283–92.

    Google Scholar 

  2. Petit D, Touchette E, Tremblay RE, et al. Dyssomnias and parasomnias in early childhood. Pediatrics. 2007;5:e1016–25.

    Google Scholar 

  3. Waters F, Moretto U, Dang-Vu TT. Psychiatric illness and parasomnias: a systematic review. Curr Psychiatry Rep. 2007;7:37.

    Google Scholar 

  4. Irfan M, Schenck CH, Howell MJ. Non-rapid eye movement sleep and overlap parasomnias. Continuum. 2017;4:1035–50.

    Google Scholar 

  5. Hublin C, Kaprio J, Partinen M, et al. Prevalence and genetics of sleepwalking: a population-based twin study. Neurology. 1997;1:177–81.

    Google Scholar 

  6. Kales A, Soldatos CR, Bixler EO, et al. Hereditary factors in sleepwalking and night terrors. Br J Psychiatry. 1980;137:111–8.

    CAS  PubMed  Google Scholar 

  7. Ohayon MM, Guilleminault C, Priest RG. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry. 1999;4:268–76.

    Google Scholar 

  8. Guilleminault C, Kirisoglu C, Bao G, et al. Adult chronic sleepwalking and its treatment based on polysomnography. Brain. 2005;Pt 5:1062–9.

    Google Scholar 

  9. Lundetrae RS, Saxvig IW, Pallesen S, et al. Prevalence of parasomnias in patients with obstructive sleep apnea. A registry-based cross-sectional study. Front Psychol. 2018;9:1140.

    PubMed  PubMed Central  Google Scholar 

  10. Singh S, Kaur H, Singh S, et al. Parasomnias: a comprehensive review. Cureus. 2018;12:e3807.

    Google Scholar 

  11. Lam SP, Fong SY, Ho CK, et al. Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. J Clin Psychiatry. 2008;9:1374–82.

    Google Scholar 

  12. Rekling JC, Funk GD, Bayliss DA, et al. Synaptic control of motoneuronal excitability. Physiol Rev. 2000;2:767–852.

    Google Scholar 

  13. Jacobs BL, Fornal CA. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology. 1999;2:9S–15S.

    Google Scholar 

  14. Stallman HM, Kohler M, White J. Medication induced sleepwalking: a systematic review. Sleep Med Rev. 2018;37:105–13.

    PubMed  Google Scholar 

  15. Pressman MR. Disorders of arousal from sleep and violent behavior: the role of physical contact and proximity. Sleep. 2007;8:1039–47.

    Google Scholar 

  16. Bodkin CL, Schenck CH. Rapid eye movement sleep behavior disorder in women: relevance to general and specialty medical practice. J Women’s Health. 2009;12:1955–63.

    Google Scholar 

  17. Schenck CH, Mahowald MW. REM sleep parasomnias. Neurol Clin. 1996;4:697–720.

    Google Scholar 

  18. Berlin RM, Qayyum U. Sleepwalking: diagnosis and treatment through the life cycle. Psychosomatics. 1986;11:755–60.

    Google Scholar 

  19. Mendelson WB, Garnett D, Gillin JC. Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Nerv Ment Dis. 1981;4:261–4.

    Google Scholar 

  20. Marshall JR. The treatment of night terrors associated with the posttraumatic syndrome. Am J Psychiatry. 1975;3:293–5.

    Google Scholar 

  21. Cooper AJ. Treatment of coexistent night-terrors and somnambulism in adults with imipramine and diazepam. J Clin Psychiatry. 1987;5:209–10.

    Google Scholar 

  22. Garland EJ, Smith DH. Simultaneous prepubertal onset of panic disorder, night terrors, and somnambulism. J Am Acad Child Adolesc Psychiatry. 1991;4:553–5.

    Google Scholar 

  23. Lillywhite AR, Wilson SJ, Nutt DJ. Successful treatment of night terrors and somnambulism with paroxetine. Br J Psychiatry. 1994;4:551–4.

    Google Scholar 

  24. Guilleminault C, Moscovitch A, Yuen K, et al. Atypical sexual behavior during sleep. Psychosom Med. 2002;2:328–36.

    Google Scholar 

  25. Ohayon MM, Priest RG, Zulley J, et al. The place of confusional arousals in sleep and mental disorders: findings in a general population sample of 13,057 subjects. J Nerv Ment Dis. 2000;6:340–8.

    Google Scholar 

  26. Galbiati A, Rinaldi F, Giora E, et al. Behavioural and cognitive-behavioural treatments of parasomnias. Behav Neurol. 2015;2015:786928.

    PubMed  PubMed Central  Google Scholar 

  27. Attarian H. Treatment options for parasomnias. Neurol Clin. 2010;4:1089–106.

    Google Scholar 

  28. Gau SF, Soong WT. Psychiatric comorbidity of adolescents with sleep terrors or sleepwalking: a case-control study. Aust N Z J Psychiatry. 1999;5:734–9.

    Google Scholar 

  29. Lask B. Novel and non-toxic treatment for night terrors. BMJ. 1988;6648:592.

    Google Scholar 

  30. Kales JC, Cadieux RJ, Soldatos CR, et al. Psychotherapy with night-terror patients. Am J Psychother. 1982;3:399–407.

    Google Scholar 

  31. Kellerman J. Behavioral treatment of night terrors in a child with acute leukemia. J Nerv Ment Dis. 1979;3:182–5.

    Google Scholar 

  32. Hurwitz TD, Mahowald MW, Schenck CH, et al. A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror. J Nerv Ment Dis. 1991;4:228–33.

    Google Scholar 

  33. Kaur H, Jahngir MU, Siddiqui JH. Sleep-related eating disorder in a patient with Parkinson’s disease. Cureus. 2018;9:e3345.

    Google Scholar 

  34. Poryazova R, Oberholzer M, Baumann CR, et al. REM sleep behavior disorder in Parkinson’s disease: a questionnaire-based survey. J Clin Sleep Med. 2013;1:55–9.

    Google Scholar 

  35. Teman PT, Tippmann-Peikert M, Silber MH, et al. Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med. 2009;1:60–5.

    Google Scholar 

  36. Schenck CH, Hurwitz TD, O’Connor KA, et al. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep. 1993;5:457–66.

    Google Scholar 

  37. Winkelman JW. Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry. 1998;1:14–9.

    Google Scholar 

  38. Howell MJ, Schenck CH, Crow SJ. A review of nighttime eating disorders. Sleep Med Rev. 2009;1:23–34.

    Google Scholar 

  39. Winkelman JW. Sleep-related eating disorder and night eating syndrome: sleep disorders, eating disorders, or both? Sleep. 2006;7:876–7.

    Google Scholar 

  40. Palmese LB, Ratliff JC, Reutenauer EL, et al. Prevalence of night eating in obese individuals with schizophrenia and schizoaffective disorder. Compr Psychiatry. 2013;3:276–81.

    Google Scholar 

  41. Paquet V, Strul J, Servais L, et al. Sleep-related eating disorder induced by olanzapine. J Clin Psychiatry. 2002;7:597.

    Google Scholar 

  42. Lu ML, Shen WW. Sleep-related eating disorder induced by risperidone. J Clin Psychiatry. 2004;2:273–4.

    Google Scholar 

  43. Wing YK, Lam SP, Li SX, et al. Sleep-related eating disorder and zolpidem: an open interventional cohort study. J Clin Psychiatry. 2010;5:653–6.

    Google Scholar 

  44. Shinith D, Mathilakath A, Kim DI, et al. Sleep-related eating disorder with mirtazapine. BMJ Case Rep. 2018;1757–90.

    Google Scholar 

  45. Kobayashi N, Takano M. Aripiprazole-induced sleep-related eating disorder: a case report. J Med Case Rep. 2018;1:91.

    Google Scholar 

  46. Morgenthaler TI, Silber MH. Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med. 2002;4:323–7.

    Google Scholar 

  47. Proserpio P, Terzaghi M, Manni R, et al. Drugs used in parasomnia. Sleep Med Clin. 2018;2:191–202.

    Google Scholar 

  48. Chiaro G, Caletti MT, Provini F. Treatment of sleep-related eating disorder. Curr Treat Options Neurol. 2015;8:361.

    Google Scholar 

  49. Howell MJ, Schenck CH. Treatment of nocturnal eating disorders. Curr Treat Options Neurol. 2009;5:333–9.

    Google Scholar 

  50. Miyaoka T, Yasukawa R, Tsubouchi K, et al. Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol. 2003;3:175–7.

    Google Scholar 

  51. Santin J, Mery V, Elso MJ, et al. Sleep-related eating disorder: a descriptive study in Chilean patients. Sleep Med. 2014;2:163–7.

    Google Scholar 

  52. Bejot Y, Juenet N, Garrouty R, et al. Sexsomnia: an uncommon variety of parasomnia. Clin Neurol Neurosurg. 2010;1:72–5.

    Google Scholar 

  53. Schenck CH, Arnulf I, Mahowald MW. Sleep and sex: what can go wrong? A review of the literature on sleep related disorders and abnormal sexual behaviors and experiences. Sleep. 2007;6:683–702.

    Google Scholar 

  54. Martynowicz H, Smardz J, Wieczorek T, et al. The co-occurrence of Sexsomnia, sleep bruxism and other sleep disorders. J Clin Med. 2018;9:233.

    Google Scholar 

  55. Krol DG. Sexsomnia during treatment with a selective serotonin reuptake inhibitor. Tijdschr Psychiatr. 2008;11:735–9.

    Google Scholar 

  56. Pelin Z, Yazla E. Abnormal sexual behavior during sleep in temporal lobe epilepsy: a case report. Balkan Med J. 2012;J2:211–3.

    Google Scholar 

  57. Soca R, Keenan JC, Schenck CH. Parasomnia overlap disorder with sexual behaviors during sleep in a patient with obstructive sleep apnea. J Clin Sleep Med. 2016;8:1189–91.

    Google Scholar 

  58. Andersen ML, Poyares D, Alves RS, et al. Sexsomnia: abnormal sexual behavior during sleep. Brain Res Rev. 2007;2:271–82.

    Google Scholar 

  59. Guilleminault C, Leger D, Philip P, et al. Nocturnal wandering and violence: review of a sleep clinic population. J Forensic Sci. 1998;1:158–63.

    Google Scholar 

  60. Contreras JB, Richardson J, Kotagal S. Sexsomnia in an adolescent. J Clin Sleep Med. 2019;3:505–7.

    Google Scholar 

  61. McRae L. Blaming rape on sleep: a psychoanalytic intervention. Int J Law Psychiatry. 2019;62:135–47.

    PubMed  Google Scholar 

  62. Mariotti P, Quaranta D, Di Giacopo R, et al. Rapid eye movement sleep behavior disorder: a window on the emotional world of Parkinson disease. Sleep. 2015;2:287–94.

    Google Scholar 

  63. Howell MJ, Schenck CH. Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol. 2015;6:707–12.

    Google Scholar 

  64. Dauvilliers Y, Jennum P, Plazzi G. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy. Sleep Med. 2013;8:775–81.

    Google Scholar 

  65. Haba-Rubio J, Frauscher B, Marques-Vidal P, et al. Prevalence and determinants of REM sleep behavior disorder in the general population. Sleep. 2017;41:197.

    Google Scholar 

  66. Kang SH, Yoon IY, Lee SD, et al. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep. 2013;8:1147–52.

    Google Scholar 

  67. Eisensehr I, Lindeiner H v, Jager M, et al. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson’s disease: is there a need for polysomnography? J Neurol Sci. 2001;1:7–11.

    Google Scholar 

  68. Plomhause L, Dujardin K, Duhamel A, et al. Rapid eye movement sleep behavior disorder in treatment-naive Parkinson disease patients. Sleep Med. 2013;10:1035–7.

    Google Scholar 

  69. Palma JA, Fernandez-Cordon C, Coon EA, et al. Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis. Clin Auton Res. 2015;1:69–75.

    Google Scholar 

  70. Plazzi G, Corsini R, Provini F, et al. REM sleep behavior disorders in multiple system atrophy. Neurology. 1997;4:1094–7.

    Google Scholar 

  71. Boeve BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci. 2010;1184:15–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Tachibana N, Oka Y. Longitudinal change in REM sleep components in a patient with multiple system atrophy associated with REM sleep behavior disorder: paradoxical improvement of nocturnal behaviors in a progressive neurodegenerative disease. Sleep Med. 2004;2:155–8.

    Google Scholar 

  73. Lloyd R, Tippmann-Peikert M, Slocumb N, et al. Characteristics of REM sleep behavior disorder in childhood. J Clin Sleep Med. 2012;2:127–31.

    Google Scholar 

  74. Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;8:744–8.

    Google Scholar 

  75. Iranzo A, Fernandez-Arcos A, Tolosa E, et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One. 2014;2:e89741.

    Google Scholar 

  76. Tribl GG, Trindade MC, Bittencourt T, et al. Wilson’s disease with and without rapid eye movement sleep behavior disorder compared to healthy matched controls. Sleep Med. 2016;17:179–85.

    PubMed  Google Scholar 

  77. Arnulf I, Nielsen J, Lohmann E, et al. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol. 2008;4:482–8.

    Google Scholar 

  78. Shindo K, Sato T, Murata H, et al. Spinocerebellar ataxia type 31 associated with REM sleep behavior disorder: a case report. BMC Neurol. 2019;1:9.

    Google Scholar 

  79. Chokroverty S, Bhat S, Rosen D, et al. REM behavior disorder in myotonic dystrophy type 2. Neurology. 2012;24:2004.

    Google Scholar 

  80. McCarter SJ, Tippmann-Peikert M, Sandness DJ, et al. Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder. Sleep Med. 2015;12:1502–10.

    Google Scholar 

  81. Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol. 1992;1:3–10.

    Google Scholar 

  82. Dauvilliers Y, Rompre S, Gagnon JF, et al. REM sleep characteristics in narcolepsy and REM sleep behavior disorder. Sleep. 2007;7:844–9.

    Google Scholar 

  83. Nevsimalova S, Pisko J, Buskova J, et al. Narcolepsy: clinical differences and association with other sleep disorders in different age groups. J Neurol. 2013;3:767–75.

    Google Scholar 

  84. Hoque R, Chesson AL Jr. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med. 2010;1:79–83.

    Google Scholar 

  85. Ju YE, Larson-Prior L, Duntley S. Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med. 2011;3:278–83.

    Google Scholar 

  86. Frauscher B, Jennum P, Ju YE, et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology. 2014;12:1076–9.

    Google Scholar 

  87. Lee K, Baron K, Soca R, et al. The prevalence and characteristics of REM sleep without atonia (RSWA) in patients taking antidepressants. J Clin Sleep Med. 2016;3:351–5.

    Google Scholar 

  88. Postuma RB, Gagnon JF, Pelletier A, et al. Prodromal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord. 2013;5:597–604.

    Google Scholar 

  89. Wing YK, Lam SP, Zhang J, et al. Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression. Neurology. 2015;5:516–22.

    Google Scholar 

  90. Gaig C, Iranzo A, Pujol M, et al. Periodic limb movements during sleep mimicking REM sleep behavior disorder: a new form of periodic limb movement disorder. Sleep. 2017;3:1.

    Google Scholar 

  91. Howell MJ. Parasomnias: an updated review. Neurotherapeutics. 2012;4:753–75.

    Google Scholar 

  92. Schenck CH, Boyd JL, Mahowald MW. A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep. 1997;11:972–81.

    Google Scholar 

  93. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123:331–9.

    PubMed  Google Scholar 

  94. Zhang J, Lam SP, Ho CK, et al. Diagnosis of REM sleep behavior disorder by video-polysomnographic study: is one night enough? Sleep. 2008;8:1179–85.

    CAS  Google Scholar 

  95. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;2:120–38.

    Google Scholar 

  96. Li SX, Lam SP, Zhang J, et al. A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder. Sleep Med. 2016;21:114–20.

    PubMed  Google Scholar 

  97. Kunz D, Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res. 2010;4:591–606.

    Google Scholar 

  98. McCarter SJ, Boswell CL, St Louis EK, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Med. 2013;3:237–42.

    Google Scholar 

  99. Di Giacopo R, Fasano A, Quaranta D, et al. Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson’s disease. Mov Disord. 2012;4:559–61.

    Google Scholar 

  100. Brunetti V, Losurdo A, Testani E, et al. Rivastigmine for refractory REM behavior disorder in mild cognitive impairment. Curr Alzheimer Res. 2014;3:267–73.

    Google Scholar 

  101. Sasai T, Inoue Y, Matsuura M. Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder. Tohoku J Exp Med. 2012;3:177–81.

    Google Scholar 

  102. Sasai T, Matsuura M, Inoue Y. Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord. 2013;2:153–7.

    Google Scholar 

  103. Chagas MH, Eckeli AL, Zuardi AW, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series. J Clin Pharm Ther. 2014;5:564–6.

    Google Scholar 

  104. Howell MJ, Arneson PA, Schenck CH. A novel therapy for REM sleep behavior disorder (RBD). J Clin Sleep Med. 2011;6:639–44.

    Google Scholar 

  105. Schenck CH, Lee SA, Bornemann MA, et al. Potentially lethal behaviors associated with rapid eye movement sleep behavior disorder: review of the literature and forensic implications. J Forensic Sci. 2009;6:1475–84.

    Google Scholar 

  106. Zadra A, Donderi DC. Nightmares and bad dreams: their prevalence and relationship to well-being. J Abnorm Psychol. 2000;2:273–81.

    Google Scholar 

  107. Steinsbekk S, Berg-Nielsen TS, Wichstrom L. Sleep disorders in preschoolers: prevalence and comorbidity with psychiatric symptoms. J Dev Behav Pediatr. 2013;9:633–41.

    Google Scholar 

  108. Hublin C, Kaprio J, Partinen M, et al. Nightmares: familial aggregation and association with psychiatric disorders in a nationwide twin cohort. Am J Med Genet. 1999;4:329–36.

    Google Scholar 

  109. Swart ML, van Schagen AM, Lancee J, et al. Prevalence of nightmare disorder in psychiatric outpatients. Psychother Psychosom. 2013;4:267–8.

    Google Scholar 

  110. Besiroglu L, Agargun MY, Inci R. Nightmares and terminal insomnia in depressed patients with and without melancholic features. Psychiatry Res. 2005;2:285–7.

    Google Scholar 

  111. Sjostrom N, Waern M, Hetta J. Nightmares and sleep disturbances in relation to suicidality in suicide attempters. Sleep. 2007;1:91–5.

    Google Scholar 

  112. Sheaves B, Onwumere J, Keen N, et al. Nightmares in patients with psychosis: the relation with sleep, psychotic, affective, and cognitive symptoms. Can J Psychiatr. 2015;8:354–61.

    Google Scholar 

  113. Waters F, Faulkner D, Naik N, et al. Effects of polypharmacy on sleep in psychiatric inpatients. Schizophr Res. 2012;1:225–8.

    Google Scholar 

  114. Li SX, Lam SP, Zhang J, et al. Sleep disturbances and suicide risk in an 8-year longitudinal study of schizophrenia-spectrum disorders. Sleep. 2016;6:1275–82.

    Google Scholar 

  115. Malhotra RK, Avidan AY. Parasomnias and their mimics. Neurol Clin. 2012;4:1067–94.

    Google Scholar 

  116. Davis JL, Wright DC. Randomized clinical trial for treatment of chronic nightmares in trauma-exposed adults. J Trauma Stress. 2007;2:123–33.

    Google Scholar 

  117. Hauri PJ, Silber MH, Boeve BF. The treatment of parasomnias with hypnosis: a 5-year follow-up study. J Clin Sleep Med. 2007;4:369–73.

    Google Scholar 

  118. Silver SM, Brooks A, Obenchain J. Treatment of Vietnam War veterans with PTSD: a comparison of eye movement desensitization and reprocessing, biofeedback, and relaxation training. J Trauma Stress. 1995;2:337–42.

    Google Scholar 

  119. George KC, Kebejian L, Ruth LJ, et al. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. J Trauma Dissociation. 2016;4:494–510.

    Google Scholar 

  120. Cameron C, Watson D, Robinson J. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation. J Clin Psychopharmacol. 2014;5:559–64.

    Google Scholar 

  121. Jetly R, Heber A, Fraser G, et al. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology. 2015;51:585–8.

    CAS  PubMed  Google Scholar 

  122. Antelmi E, Ferri R, Iranzo A, et al. From state dissociation to status dissociatus. Sleep Med Rev. 2016;28:5–17.

    PubMed  Google Scholar 

  123. Lugaresi E, Provini F. Agrypnia excitata: clinical features and pathophysiological implications. Sleep Med Rev. 2001;4:313–22.

    Google Scholar 

  124. Plazzi G, Schutz Y, Cortelli P, et al. Motor overactivity and loss of motor circadian rhythm in fatal familial insomnia: an actigraphic study. Sleep. 1997;9:739–42.

    Google Scholar 

  125. Montagna P, Lugaresi E. Agrypnia Excitata: a generalized overactivity syndrome and a useful concept in the neurophysiopathology of sleep. Clin Neurophysiol. 2002;4:552–60.

    Google Scholar 

  126. Mahowald MW, Schenck CH. Status dissociatus – a perspective on states of being. Sleep. 1991;1:69–79.

    Google Scholar 

  127. Vetrugno R, Alessandria M, D’Angelo R, et al. Status dissociatus evolving from REM sleep behaviour disorder in multiple system atrophy. Sleep Med. 2009;2:247–52.

    Google Scholar 

  128. Arnulf I, Mabrouk T, Mohamed K, et al. Stages 1-2 non-rapid eye movement sleep behavior disorder associated with dementia: a new parasomnia? Mov Disord. 2005;9:1223–8.

    Google Scholar 

  129. Miro-Andreu A, Lopez-Bernabe R, Garnes Sanchez MC, et al. Status dissociatus: the most extreme expression of state dissociation. Neurologia. 2019;3:209–11.

    Google Scholar 

  130. Guilleminault C, Hagen CC, Khaja AM. Catathrenia: parasomnia or uncommon feature of sleep disordered breathing? Sleep. 2008;1:132–9.

    Google Scholar 

  131. Prihodova I, Sonka K, Kemlink D, et al. Arousals in nocturnal groaning. Sleep Med. 2009;9:1051–5.

    Google Scholar 

  132. Iriarte J, Campo A, Alegre M, et al. Catathrenia: respiratory disorder or parasomnia? Sleep Med. 2015;7:827–30.

    Google Scholar 

  133. Pevernagie DA. Why catathrenia is a parasomnia. Sleep Med. 2017;32:227–8.

    PubMed  Google Scholar 

  134. Alonso J, Camacho M, Chhetri DK, et al. Catathrenia (nocturnal groaning): a social media survey and state-of-the-art review. J Clin Sleep Med. 2017;4:613–22.

    Google Scholar 

  135. Dar MA, Gupta R. Catathrenia: a rare disorder presenting as daytime sleepiness and headache. Neurol India. 2017;3:633–6.

    Google Scholar 

  136. Dias C, Sousa L, Batata L, et al. CPAP treatment for catathrenia. Rev Port Pneumol. 2017;2:101–4.

    Google Scholar 

  137. Sharpless BA, Grom JL. Isolated sleep paralysis: fear, prevention, and disruption. Behav Sleep Med. 2016;2:134–9.

    Google Scholar 

  138. Sharpless BA, Barber JP. Lifetime prevalence rates of sleep paralysis: a systematic review. Sleep Med Rev. 2011;5:311–5.

    Google Scholar 

  139. Bell CC, Dixie-Bell DD, Thompson B. Further studies on the prevalence of isolated sleep paralysis in black subjects. J Natl Med Assoc. 1986;7:649–59.

    Google Scholar 

  140. Denis D, French CC, Rowe R, et al. A twin and molecular genetics study of sleep paralysis and associated factors. J Sleep Res. 2015;4:438–46.

    Google Scholar 

  141. Ohayon MM, Zulley J, Guilleminault C, et al. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology. 1999;6:1194–200.

    Google Scholar 

  142. Vernet C, Redolfi S, Attali V, et al. Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms. Eur Respir J. 2011;1:98–105.

    Google Scholar 

  143. Kotorii T, Kotorii T, Uchimura N, et al. Questionnaire relating to sleep paralysis. Psychiatry Clin Neurosci. 2001;3:265–6.

    Google Scholar 

  144. Denis D, French CC, Gregory AM. A systematic review of variables associated with sleep paralysis. Sleep Med Rev. 2018;38:141–57.

    PubMed  Google Scholar 

  145. Sharpless BA, McCarthy KS, Chambless DL, et al. Isolated sleep paralysis and fearful isolated sleep paralysis in outpatients with panic attacks. J Clin Psychol. 2010;12:1292–306.

    Google Scholar 

  146. Mellman TA, Aigbogun N, Graves RE, et al. Sleep paralysis and trauma, psychiatric symptoms and disorders in an adult African American population attending primary medical care. Depress Anxiety. 2008;5:435–40.

    Google Scholar 

  147. Solomonova E, Nielsen T, Stenstrom P, et al. Sensed presence as a correlate of sleep paralysis distress, social anxiety and waking state social imagery. Conscious Cogn. 2008;1:49–63.

    Google Scholar 

  148. Hinton DE, Pich V, Chhean D, et al. ‘The ghost pushes you down’: sleep paralysis-type panic attacks in a Khmer refugee population. Transcult Psychiatry. 2005;1:46–77.

    Google Scholar 

  149. Hinton DE, Pich V, Chhean D, et al. Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severity. Depress Anxiety. 2005;2:47–51.

    Google Scholar 

  150. Paradis C, Friedman S, Hinton DE, et al. The assessment of the phenomenology of sleep paralysis: the Unusual Sleep Experiences Questionnaire (USEQ). CNS Neurosci Ther. 2009;3:220–6.

    Google Scholar 

  151. Sharpless BA. A clinician’s guide to recurrent isolated sleep paralysis. Neuropsychiatr Dis Treat. 2016;12:1761–77.

    PubMed  PubMed Central  Google Scholar 

  152. Koran LM, Raghavan S. Fluoxetine for isolated sleep paralysis. Psychosomatics. 1993;2:184–7.

    Google Scholar 

  153. Hishikawa Y, Ida H, Nakai K, et al. Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran). J Neurol Sci. 1996;5:453–61.

    Google Scholar 

  154. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep. 2002;1:42–9.

    Google Scholar 

  155. Mamelak M, Black J, Montplaisir J, et al. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep. 2004;7:1327–34.

    Google Scholar 

  156. Pearce JM. Clinical features of the exploding head syndrome. J Neurol Neurosurg Psychiatry. 1989;7:907–10.

    Google Scholar 

  157. Sharpless BA. Characteristic symptoms and associated features of exploding head syndrome in undergraduates. Cephalalgia. 2018;3:595–9.

    Google Scholar 

  158. Sharpless BA. Exploding head syndrome is common in college students. J Sleep Res. 2015;4:447–9.

    Google Scholar 

  159. Ceriani CEJ, Nahas SJ. Exploding head syndrome: a review. Curr Pain Headache Rep. 2018;10:63.

    Google Scholar 

  160. Ganguly G, Mridha B, Khan A, et al. Exploding head syndrome: a case report. Case Rep Neurol. 2013;1:14–7.

    Google Scholar 

  161. Sachs C, Svanborg E. The exploding head syndrome: polysomnographic recordings and therapeutic suggestions. Sleep. 1991;3:263–6.

    Google Scholar 

  162. Palikh GM, Vaughn BV. Topiramate responsive exploding head syndrome. J Clin Sleep Med. 2010;4:382–3.

    Google Scholar 

  163. Jacome DE. Exploding head syndrome and idiopathic stabbing headache relieved by nifedipine. Cephalalgia. 2001;5:617–8.

    Google Scholar 

  164. Mason TB 2nd, Pack AI. Sleep terrors in childhood. J Pediatr. 2005;3:388–92.

    Google Scholar 

  165. Cochen De Cock V. Sleepwalking. Curr Treat Options Neurol. 2016;2:6.

    Google Scholar 

  166. Attarian H, Zhu L. Treatment options for disorders of arousal: a case series. Int J Neurosci. 2013;9:623–5.

    Google Scholar 

  167. Wilson SJ, Lillywhite AR, Potokar JP, et al. Adult night terrors and paroxetine. Lancet. 1997;9072:185.

    Google Scholar 

  168. Ozcan O, Donmez YE. Melatonin treatment for childhood sleep terror. J Child Adolesc Psychopharmacol. 2014;9:528–9.

    Google Scholar 

  169. Bruni O, Ferri R, Miano S, et al. L −5-Hydroxytryptophan treatment of sleep terrors in children. Eur J Pediatr. 2004;7:402–7.

    Google Scholar 

  170. Sasayama D, Washizuka S, Honda H. Effective treatment of night terrors and sleepwalking with Ramelteon. J Child Adolesc Psychopharmacol. 2016;10:948.

    Google Scholar 

  171. Mallapareddi A, Varghese R. A case of Buspirone demonstrating immediate and sustained benefit in a man with lifelong non-rapid-eye-movement parasomnias. Clin Neuropharmacol. 2019;2:52–4.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen S. Carvalho .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Khurana, D.S., Carvalho, K.S. (2020). Parasomnia. In: Sedky, K., Nazir, R., Bennett, D. (eds) Sleep Medicine and Mental Health. Springer, Cham. https://doi.org/10.1007/978-3-030-44447-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-44447-1_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-44446-4

  • Online ISBN: 978-3-030-44447-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics